METAP2 and obesity due to melanocortin 4 receptor deficiency: Beloranib (Zafgen®) is a novel injectable anti-obesity agent that can promote intracellular reduction in fat biosynthesis and fat oxidation and lipolysis by inhibition of methionine aminopeptidase-2 (MetAP2).